search
Back to results

WALANT Procedure in Carpal Tunnel Release

Primary Purpose

Carpal Tunnel, Median Nerve Neuralgia, Anesthesia, Local

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Experimental: WALANT procedure
Active Comparator: Axial ALR
Active Comparator: Truncal ALR
Sponsored by
Elsan
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Carpal Tunnel

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Male or female patient over 18 years of age
  • Membership in a mandatory health insurance plan
  • Patient treated for a first median nerve liberation surgery at the carpal tunnel
  • Patient having been informed of the study and having given informed consent
  • French-speaking patient

Exclusion Criteria:

  • Surgical revision
  • Contraindication(s) to loco-regional anesthesia :

    1. Coagulation disorder or ongoing anticoagulant therapy
    2. Existing peripheral neuropathy
    3. Amide-type AL allergy
  • Pregnant or breastfeeding women
  • Inability to undergo the medical follow-up of the study for geographical, social or psychological reasons
  • Patients under legal protection
  • Patients under the influence of drugs that may interfere with the anesthetic techniques under study (cocaine, cannabis, etc. as judged by the investigator)
  • Inclusion of the subject in another research protocol during this study

Sites / Locations

  • Institut de la main Nantes Atlantique

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Active Comparator

Arm Label

WALANT procedure

Axial ALR

Truncal ALR

Arm Description

Local anesthesia of the WALANT type

Axillary loco-regional anesthesia

Truncal loco-regional anesthesia

Outcomes

Primary Outcome Measures

Evaluation of the patient's pain intraoperatively at the surgical site.
Evaluation of the patient's pain, at the level of the operative site by a visual analog scale from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain".

Secondary Outcome Measures

Visual Analog Scale for intraoperative pain at the surgical site
The assessment of pain at the surgical site will be evaluated using a 10-point visual analog scale score from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"
Satisfaction scores
Satisfaction scores according to the forms provided in the appendices of the anaesthetist and the surgeon
Satisfaction scores
Satisfaction scores according to the forms provided in the appendices of the patient
Assessment of the patient's overall pain after surgery
Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"
Assessment of the patient's overall pain after surgery
Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"
Assessment of the patient's overall pain after surgery
Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"
Assessment of the patient's overall pain after surgery
Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"
Evaluation of the return to work after surgery
Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to "No disability" and 100 equals to "Most severe disability and reduced function"
Evaluation of the return to work after surgery
Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to "No disability" and 100 equals to "Most severe disability and reduced function"
Evaluation of the return to work after surgery
Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to "No disability" and 100 equals to "Most severe disability and reduced function"
Evaluation of the return to work after surgery
Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to "No disability" and 100 equals to "Most severe disability and reduced function"
Evaluation of the quality of life
Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to "Poor Health" and 100 equals to "Good Health"
Evaluation of the quality of life
Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to "Poor Health" and 100 equals to "Good Health"
Evaluation of the quality of life
Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to "Poor Health" and 100 equals to "Good Health"
Evaluation of the quality of life
Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to "Poor Health" and 100 equals to "Good Health"
Evaluation of the use of analgesics in the postoperative situation
The use of analgesics will be collected until D+1 by defining the following levels of analgesic intake: Level I: use of a paracetamol-type analgesic, up to 4 g/day Level II: use of another type of analgesic (Tramadol or Lamaline®)
Evaluation of the failure rates of different anesthesia procedures.
The following were considered procedural failures: need for intravenous sedation for all 3 groups, need to inflate the tourniquet (applied as a preventive measure) for the WALANT group only.
Evaluation of the operative time.
Operating time defined as the time from skin incision to skin closure (in minutes)
Evaluation of the hospitalization length.
Hospitalization length defined as the time from the patient's admission to the end of the hospitalization (in hours)
Evaluation of the time to release of anesthesia.
Time to release of anesthesia defined as the time from the placement of anesthesia to the release of motor (ability to clench/unclench the hand) and sensory (disappearance of tingling) anesthesia
Evaluation of the safety of different types of anesthesia.
Collection of postoperative adverse events.

Full Information

First Posted
May 24, 2021
Last Updated
March 9, 2023
Sponsor
Elsan
search

1. Study Identification

Unique Protocol Identification Number
NCT04924348
Brief Title
WALANT Procedure in Carpal Tunnel Release
Official Title
WALANT (Wide Awake Local Anaesthesia With No Tourniquet) Procedure in Carpal Tunnel Release: a Prospective Randomized Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
December 2, 2020 (Actual)
Primary Completion Date
February 15, 2022 (Actual)
Study Completion Date
January 25, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Elsan

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The possible benefits expected from the use of the WALANT procedure are a decrease in intraoperative pain at the surgical site, a decrease in hospitalization time, and a decrease in the time required to lift the anesthesia postoperatively. The risks identified are those inherent to each type of anesthesia (WALANT or traditional ALR), as encountered in current practice, and are therefore not specific to the study: risks related to the local anesthetic agent or risks related to the puncture procedure. The main objective is to determine whether the patient's intraoperative pain at the surgical site is less after a WALANT procedure compared to a traditional ALR procedure (axillary or trunk).
Detailed Description
Median nerve neurolysis at the carpal tunnel is one of the most performed procedures in the world. The use of loco-regional anesthesia (LRA) is common practice for this surgery, especially since the use of ultrasound guidance, which allows visualization of the nerves and control of the injection of anesthetic products, makes it a safe technique. The nerve blocks most commonly used in hand surgery are axillary blocks and truncal blocks. The choice between these two techniques, which are equivalent in terms of effectiveness and duration of anesthesia, depends in practice on the habits of each practitioner. As the use of a pneumatic tourniquet during the operation is systematic, the axillary block, by anaesthetizing the whole arm, avoids the discomfort described by some patients when using a tourniquet. For others, the discomfort is related to the sensation of a "dead arm" with a duration of anesthesia of several hours, which the truncular block makes it possible to avoid. Recently, an alternative to traditional LRA by local anesthesia without tourniquet and without sedation (WALANT procedure: Wide Awake Local Anesthesia with No Tourniquet) has been described. Several studies show the efficacy and safety of this procedure, which is already used in current practice. However, to date, there is no comparative study evaluating the effectiveness of the WALANT procedure compared to traditional hand surgery techniques for carpal tunnel, neither published nor in progress. This is the purpose of this study. The WALANT technique, performed under ultrasound, includes two punctures. The first is a puncture through a medial approach above the wrist and includes two injections. A first subcutaneous injection reproducing a bar above the wrist flexion line, and a second injection above the median nerve. The volumes injected vary from 8 to 10 milliliters (ml). The second puncture is performed at the base of the palmar surface of the hand and consists of a 10 ml subcutaneous injection of the local anesthetic in order to take advantage of the vasoconstrictive effects of adrenaline, thus allowing the surgical procedure to be performed without a pneumatic tourniquet.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Carpal Tunnel, Median Nerve Neuralgia, Anesthesia, Local

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Interventional, prospective, therapeutic, comparative, randomized controlled open-label, non-inferiority, single-center, national study.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
144 (Actual)

8. Arms, Groups, and Interventions

Arm Title
WALANT procedure
Arm Type
Experimental
Arm Description
Local anesthesia of the WALANT type
Arm Title
Axial ALR
Arm Type
Active Comparator
Arm Description
Axillary loco-regional anesthesia
Arm Title
Truncal ALR
Arm Type
Active Comparator
Arm Description
Truncal loco-regional anesthesia
Intervention Type
Procedure
Intervention Name(s)
Experimental: WALANT procedure
Intervention Description
The WALANT technique, performed under ultrasound, includes two punctures. The first is a puncture through a medial approach above the wrist and includes two injections. A first subcutaneous injection reproducing a bar above the wrist flexion line, and a second injection above the median nerve. The volumes injected vary from 8 to 10 milliliters (ml). The second puncture is performed at the base of the palmar surface of the hand and consists of a 10 ml subcutaneous injection of the local anesthetic in order to take advantage of the vasoconstrictive effects of adrenaline, thus allowing the surgical procedure to be performed without a pneumatic tourniquet.
Intervention Type
Procedure
Intervention Name(s)
Active Comparator: Axial ALR
Intervention Description
The anesthetic protocol in the axillary block consists of performing a puncture, using a needle (50 mm 22G with a short bevel), under the armpit at the level of the axillary hollow after skin disinfection. This puncture, performed under ultrasound, allows the injection of the local anesthetic around the median, radial, ulnar and musculocutaneous nerves. The volume injected per nerve can vary from 5 to 8 ml depending on the visual appreciation during the injection.
Intervention Type
Procedure
Intervention Name(s)
Active Comparator: Truncal ALR
Intervention Description
The anesthetic protocol in truncal block consists in injecting the local anesthetic around the median and ulnar nerves by a puncture performed at the elbow or forearm (depending on the practitioner's experience). The volumes injected remain the same and the puncture is also performed under ultrasound guidance. Additional local anesthesia is administered by injecting an additional 5 ml above the wrist flexion line to block the sensory territory of the musculocutaneous nerve.
Primary Outcome Measure Information:
Title
Evaluation of the patient's pain intraoperatively at the surgical site.
Description
Evaluation of the patient's pain, at the level of the operative site by a visual analog scale from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain".
Time Frame
Within 24 hours after intervention
Secondary Outcome Measure Information:
Title
Visual Analog Scale for intraoperative pain at the surgical site
Description
The assessment of pain at the surgical site will be evaluated using a 10-point visual analog scale score from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"
Time Frame
intraoperative
Title
Satisfaction scores
Description
Satisfaction scores according to the forms provided in the appendices of the anaesthetist and the surgeon
Time Frame
Within 24 hours after intervention
Title
Satisfaction scores
Description
Satisfaction scores according to the forms provided in the appendices of the patient
Time Frame
One day after intervention
Title
Assessment of the patient's overall pain after surgery
Description
Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"
Time Frame
One day after intervention
Title
Assessment of the patient's overall pain after surgery
Description
Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"
Time Frame
One month after intervention
Title
Assessment of the patient's overall pain after surgery
Description
Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"
Time Frame
Three months after intervention
Title
Assessment of the patient's overall pain after surgery
Description
Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"
Time Frame
Six months after intervention
Title
Evaluation of the return to work after surgery
Description
Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to "No disability" and 100 equals to "Most severe disability and reduced function"
Time Frame
Within 24 hours after intervention
Title
Evaluation of the return to work after surgery
Description
Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to "No disability" and 100 equals to "Most severe disability and reduced function"
Time Frame
One month after intervention
Title
Evaluation of the return to work after surgery
Description
Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to "No disability" and 100 equals to "Most severe disability and reduced function"
Time Frame
Three months after intervention
Title
Evaluation of the return to work after surgery
Description
Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to "No disability" and 100 equals to "Most severe disability and reduced function"
Time Frame
Six months after intervention
Title
Evaluation of the quality of life
Description
Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to "Poor Health" and 100 equals to "Good Health"
Time Frame
Baseline (Before the anesthesia)
Title
Evaluation of the quality of life
Description
Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to "Poor Health" and 100 equals to "Good Health"
Time Frame
One month after intervention
Title
Evaluation of the quality of life
Description
Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to "Poor Health" and 100 equals to "Good Health"
Time Frame
Three months after intervention
Title
Evaluation of the quality of life
Description
Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to "Poor Health" and 100 equals to "Good Health"
Time Frame
Six months after intervention
Title
Evaluation of the use of analgesics in the postoperative situation
Description
The use of analgesics will be collected until D+1 by defining the following levels of analgesic intake: Level I: use of a paracetamol-type analgesic, up to 4 g/day Level II: use of another type of analgesic (Tramadol or Lamaline®)
Time Frame
One day after intervention
Title
Evaluation of the failure rates of different anesthesia procedures.
Description
The following were considered procedural failures: need for intravenous sedation for all 3 groups, need to inflate the tourniquet (applied as a preventive measure) for the WALANT group only.
Time Frame
Within 24 hours after intervention
Title
Evaluation of the operative time.
Description
Operating time defined as the time from skin incision to skin closure (in minutes)
Time Frame
During surgery
Title
Evaluation of the hospitalization length.
Description
Hospitalization length defined as the time from the patient's admission to the end of the hospitalization (in hours)
Time Frame
Within 24 hours after intervention
Title
Evaluation of the time to release of anesthesia.
Description
Time to release of anesthesia defined as the time from the placement of anesthesia to the release of motor (ability to clench/unclench the hand) and sensory (disappearance of tingling) anesthesia
Time Frame
Within 24 hours after intervention
Title
Evaluation of the safety of different types of anesthesia.
Description
Collection of postoperative adverse events.
Time Frame
One month after intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male or female patient over 18 years of age Membership in a mandatory health insurance plan Patient treated for a first median nerve liberation surgery at the carpal tunnel Patient having been informed of the study and having given informed consent French-speaking patient Exclusion Criteria: Surgical revision Contraindication(s) to loco-regional anesthesia : Coagulation disorder or ongoing anticoagulant therapy Existing peripheral neuropathy Amide-type AL allergy Pregnant or breastfeeding women Inability to undergo the medical follow-up of the study for geographical, social or psychological reasons Patients under legal protection Patients under the influence of drugs that may interfere with the anesthetic techniques under study (cocaine, cannabis, etc. as judged by the investigator) Inclusion of the subject in another research protocol during this study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Flore-Anne LECOQ, MD
Organizational Affiliation
Institut de la Main Nantes Atlantique
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institut de la main Nantes Atlantique
City
Saint-Herblain
ZIP/Postal Code
44800
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
28886668
Citation
Lalonde DH. Conceptual origins, current practice, and views of wide awake hand surgery. J Hand Surg Eur Vol. 2017 Nov;42(9):886-895. doi: 10.1177/1753193417728427. Epub 2017 Sep 8.
Results Reference
background
PubMed Identifier
28867906
Citation
Tulipan JE, Kim N, Abboudi J, Jones C, Liss F, Kirkpatrick W, Rivlin M, Wang ML, Matzon J, Ilyas AM. Open Carpal Tunnel Release Outcomes: Performed Wide Awake versus with Sedation. J Hand Microsurg. 2017 Aug;9(2):74-79. doi: 10.1055/s-0037-1603200. Epub 2017 May 22.
Results Reference
background
PubMed Identifier
25075350
Citation
Lalonde D, Martin A. Tumescent local anesthesia for hand surgery: improved results, cost effectiveness, and wide-awake patient satisfaction. Arch Plast Surg. 2014 Jul;41(4):312-6. doi: 10.5999/aps.2014.41.4.312. Epub 2014 Jul 15.
Results Reference
background
PubMed Identifier
29145985
Citation
Steiner MM, Calandruccio JH. Use of Wide-awake Local Anesthesia No Tourniquet in Hand and Wrist Surgery. Orthop Clin North Am. 2018 Jan;49(1):63-68. doi: 10.1016/j.ocl.2017.08.008.
Results Reference
background
PubMed Identifier
29409279
Citation
Wright J, MacNeill AL, Mayich DJ. A prospective comparison of wide-awake local anesthesia and general anesthesia for forefoot surgery. Foot Ankle Surg. 2019 Apr;25(2):211-214. doi: 10.1016/j.fas.2017.10.015. Epub 2017 Nov 6.
Results Reference
background
PubMed Identifier
18436467
Citation
Fayad F, Lefevre-Colau MM, Gautheron V, Mace Y, Fermanian J, Mayoux-Benhamou A, Roren A, Rannou F, Roby-Brami A, Revel M, Poiraudeau S. Reliability, validity and responsiveness of the French version of the questionnaire Quick Disability of the Arm, Shoulder and Hand in shoulder disorders. Man Ther. 2009 Apr;14(2):206-12. doi: 10.1016/j.math.2008.01.013. Epub 2008 Apr 23.
Results Reference
background
PubMed Identifier
12677622
Citation
Estebe JP, Gentili ME, Langlois G, Mouilleron P, Bernard F, Ecoffey C. Lidocaine priming reduces tourniquet pain during intravenous regional anesthesia: A preliminary study. Reg Anesth Pain Med. 2003 Mar-Apr;28(2):120-3. doi: 10.1053/rapm.2003.50123.
Results Reference
background
Links:
URL
https://www.ema.europa.eu/en/documents/scientific-guideline/points-consider-multiplicity-issues-clinical-trials_en.pdf
Description
Points to consider on multiplicity issues in clinical trials, EMEA, 2002

Learn more about this trial

WALANT Procedure in Carpal Tunnel Release

We'll reach out to this number within 24 hrs